Literature DB >> 33735107

Silencing of circular RNA_0000326 inhibits cervical cancer cell proliferation, migration and invasion by boosting microRNA-338-3p-dependent down-regulation of CDK4.

Zhaoxin Wang1,2, Chenchen Ren1, Li Yang1, Xiaoan Zhang3, Jiaxi Liu1, Yuanhang Zhu1, Dongyuan Jiang1.   

Abstract

Cervical cancer is one of the leading causes of cancer-related death among women, which is attributed partly by limited treatment options. Recent studies have provided in-depth explanations regarding the role of circular RNA in cancers. We aimed to investigate the role of circular RNA_0000326 in cervical cancer. Bioinformatics analysis revealed a high circ_0000326 expression in cervical cancer. Cervical cancer cells and tissues were also observed to have elevated levels of circ_0000326 and the upregulation of circ_0000326 depended on the stage of cancer. Transfection with siRNA of circ_0000326 resulted in the inhibition of proliferation, migration and cell cycle of cancer cells. Interestingly, we confirmed that circ_0000326 served as a sponge for microRNA-338-3p and that the miRNA bound to Cyclin-dependent kinase 4. In the presence of microRNA-338-3p mimic or silencing of circ_0000326, Cyclin-dependent kinase 4 expression was decreased. Transfection with microRNA-338-3p mimic inhibited cell clone formation and proliferation. Moreover, in vivo experiment revealed that the injection of shRNA-circ_0000326 lentivirus suppressed tumor growth and decreased Cyclin-dependent kinase 4 expression. Taken altogether, our results showed that circ_0000326 exerted oncogenic effects on cervical cancer by upregulating Cyclin-dependent kinase 4 via sponging microRNA-338-3p. This systematic investigation on circ_0000326 could provide further insight into cervical cancer.

Entities:  

Keywords:  cervical cancer; circ_0000326; circular RNA; cyclin-dependent kinase 4; microRNA-338-3p

Year:  2021        PMID: 33735107     DOI: 10.18632/aging.103711

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  7 in total

1.  Oxymatrine induces anti-tumor response in cervical cancer by modulating circ_0008460/miR-197-3p/ribonucleotide reductase subunit M2 (RRM2).

Authors:  Siwei Li; Heng Zhang; Yunping Jiao; Xiao Song; Lei Wei; Xing Liu
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 2.  A review on the role of cyclin dependent kinases in cancers.

Authors:  Soudeh Ghafouri-Fard; Tayyebeh Khoshbakht; Bashdar Mahmud Hussen; Peixin Dong; Nikolaus Gassler; Mohammad Taheri; Aria Baniahmad; Nader Akbari Dilmaghani
Journal:  Cancer Cell Int       Date:  2022-10-20       Impact factor: 6.429

3.  Construction of the circRNA-miRNA-mRNA Regulatory Network of an Abdominal Aortic Aneurysm to Explore Its Potential Pathogenesis.

Authors:  Hao Zhang; Ce Bian; Simei Tu; Fanxing Yin; Panpan Guo; Jian Zhang; Yihao Wu; Yuhan Yin; Jiahui Guo; Yanshuo Han
Journal:  Dis Markers       Date:  2021-11-05       Impact factor: 3.434

4.  MicroRNA-98-5p modulates cervical cancer progression via controlling PI3K/AKT pathway.

Authors:  RongXin Xiao; Hong Wang; Biao Yang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

5.  Circular RNA_0000326 promotes bladder cancer progression via microRNA-338-3p/ETS Proto-Oncogene 1/phosphoinositide-3 kinase/Akt pathway.

Authors:  Yong Chen; Dong Wang; Tao Shu; Kangwei Sun; Jianbo Zhao; Min Wang; Yi Huang; Ping Wang; Hang Zheng; Zhixuan Cai; Zengyue Yang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

6.  A peptide translated from circPPP1R12A promotes the malignancy of non-small cell lung cancer cells through AKT signaling pathway.

Authors:  Weijun Zhao; Yibo Xue; Yandan Zhang; Yonggang Zhu; Zixuan Chen; Xiaodong Zhao
Journal:  J Clin Lab Anal       Date:  2022-08-21       Impact factor: 3.124

7.  A Novel Circular RNA CircRFX3 Serves as a Sponge for MicroRNA-587 in Promoting Glioblastoma Progression via Regulating PDIA3.

Authors:  Tong Li; Jianguo Xu; Yi Liu
Journal:  Front Cell Dev Biol       Date:  2021-12-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.